Revance Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.7M | 194k | 8.79 |
| 2023-09-30 | $1.4M | 118k | 11.47 |
| 2023-06-30 | $3.3M | 130k | 25.31 |
| 2023-03-31 | $6.8M | 211k | 32.21 |
| 2022-12-31 | $6.5M | 353k | 18.46 |
| 2022-09-30 | $2.2M | 83k | 26.85 |
| 2022-06-30 | $1.2M | 87k | 13.82 |
| 2022-03-31 | $1.7M | 89k | 19.60 |
| 2021-12-31 | $1.4M | 85k | 16.31 |
| 2021-09-30 | $1.7M | 61k | 27.86 |
| 2021-06-30 | $1.6M | 53k | 29.63 |
| 2021-03-31 | $1.5M | 54k | 27.95 |
| 2020-12-31 | $1.4M | 48k | 28.68 |
| 2020-09-30 | $1.2M | 49k | 25.13 |
| 2020-06-30 | $1.3M | 53k | 24.41 |
| 2020-03-31 | $603k | 41k | 14.81 |
| 2019-12-31 | $1.1M | 66k | 16.04 |
| 2019-09-30 | $18k | 1.4k | 12.86 |
| 2019-06-30 | $18k | 1.4k | 12.86 |
| 2019-03-31 | $20k | 1.2k | 16.00 |
| 2018-12-31 | $9.0k | 448 | 20.09 |
| 2018-09-30 | $52k | 2.1k | 25.32 |
| 2018-06-30 | $95k | 3.4k | 27.55 |
| 2018-03-31 | $78k | 2.6k | 30.03 |
| 2017-12-31 | $85k | 2.4k | 35.71 |
| 2017-09-30 | $65k | 2.3k | 27.68 |
| 2017-06-30 | $13k | 511 | 25.44 |
| 2017-03-31 | $0 | 11 | 0.00 |
| 2016-12-31 | $22k | 1.1k | 20.98 |
| 2016-09-30 | $31k | 1.9k | 16.45 |
| 2016-06-30 | $0 | 511 | 0.00 |
| 2016-03-31 | $0 | 511 | 0.00 |
| 2015-12-31 | $64k | 1.9k | 33.81 |
| 2015-09-30 | $15k | 500 | 30.00 |
| 2015-03-31 | $13k | 657 | 19.11 |